Your monthly Inqovi cost savings if eligible
If you are eligible for the Inqovi patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Inqovi through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Inqovi patient assistance program?
You could receive your Inqovi without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Inqovi patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Inqovi.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Inqovi patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Inqovi medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx an Inqovi coupons provider?
At NiceRx, we help eligible individuals access the Inqovi patient assistance program. This means that we are not an Inqovi coupon, an Inqovi discount card, or an Inqovi copay card provider. We do not offer any medication trial offers or free Inqovi samples.
Can NiceRx help me get Inqovi if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Inqovi medication, or you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Inqovi cost without insurance?
Inqovi costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Inqovi oral tablet (100 mg-35 mg) will typically cost around $7,800 for 5 tablets. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Inqovi cost with insurance?
The copay of Inqovi will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Inqovi?
Inqovi is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Astex Pharmaceuticals, Inc. a subsidiary of Otsuka Pharmaceutical Co. Ltd.
Inqovi is a combination of decitabine, (a nucleoside metabolic inhibitor), and cedazuridine, (a cytidine deaminase inhibitor), and is used for the treatment of adult patients with myelodysplastic syndromes (MDS), (a group of blood/bone marrow disorders), including previously treated and untreated, de novo and secondary MDS with the following French, American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
The approval was based on clinical trial results which showed similar drug concentrations between intravenous decitabine and Inqovi.
What doses of Inqovi are available?
Inqovi is available in tablet form, in the following doses: 35 mg decitabine and 100 mg cedazuridine.
The recommended dosage is 1 tablet (35 mg decitabine and 100 mg cedazuridine) taken orally once daily on days 1 to 5 for five consecutive days of each 28-day cycle. Swallow the tablet whole, do not crush, chew, or break them. Take them on an empty stomach. Do not substitute Invoqi for an IV decitabine product within a treatment cycle.
Always speak with your healthcare provider for medical advice or about any changes to your dose so they can monitor and evaluate your condition.
Inqovi active ingredients
Inqovi contains the active ingredients decitabine and cedazuridine.
Inqovi side effects
The most common side effects of Inqovi in clinical trials include:
- Fatigue, dizziness, headache
- Constipation, diarrhea, decreased appetite
- Arthralgia (joint pain)
- Febrile neutropenia
- Upper respiratory tract infection, pneumonia
- Increased transaminase increased
In rare instances, Inqovi can cause more serious side effects. These can include:
- Fatal and serious myelosuppression and infectious complications can occur
- Decreased leukocytes, platelets, neutrophil count, and hemoglobin
- Thrombocytopenia (low white blood cell count)
- Embryo-fetal toxicity
Your doctor will assess the benefits of using Inqovi against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Inqovi to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Inqovi drug interactions
Inqovi can interact with other medications. These include:
- Drugs metabolized by cytidine deaminase
This list is not exhaustive and other prescription drugs may interact with Inqovi. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You should not use Inqovi if you:
- Are allergic to the active ingredient decitabine or cedazuridine
Talk to your doctor before using Inqovi if you:
- Are taking any of the medications that could interact with Inqovi
- Are pregnant or planning to become pregnant – based on findings from human data, animal studies, and its mechanism of action, Inqovi can cause fetal harm when given to a pregnant woman. You should use effective contraception during treatment and for at least 6 months after your last dose
- Are breastfeeding or plan to breastfeed
Inqovi is the trademark brand name for decitabine and cedazuridine manufactured by Astex Pharmaceuticals, Inc. A generic version of decitabine and cedazuridine is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Inqovi savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.